Cara Therapeutics | CARA - Stock

Stock Price
3.39
Daily Change
0.17 5.28%
Monthly
-1.45%
Yearly
-80.60%
Q2 Forecast
2.82

Cara Therapeutics reported $900K in Stock for its fiscal quarter ending in March of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Assertio Holdings USD 24.76M 8.12M Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Chugai Pharma JPY 246.33B 10.8B Sep/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Grifols EUR 3.56B 63.19M Dec/2024
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
J&J USD 14.19B 45M Dec/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Pacira USD 152.86M 4.82M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
RedHill Biopharma USD 3.17M 482K Jun/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025